Quantitative Marrow Imaging, Marrow Reserve, And Clinical Outcomes In Patients Undergoing Radiotherapy For Hematologic And Related Disorders
Starting soon
Conditions studied: Quantitative Marrow Imaging, Marrow Reserve, Clinical Outcomes, Radiotherapy, Hematologic
In brief
To create a registry for people who are undergoing or previously underwent radiotherapy for hematologic or related disorders.
Key facts
- Study ID
- NCT07743476
- Run by
- M.D. Anderson Cancer Center
- People needed
- 1000
- Starts
- 2027-01-23
- Expected to finish
- 2038-12-31
- Last updated by the study team
- 2026-08-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Undergoing or previously underwent radiotherapy at The University of Texas MD Anderson Cancer Center for hematologic or related disorders.
- Available clinical, imaging, laboratory, treatment, and/or outcome data relevant to study objectives.
- Ability to provide informed consent for prospective participation, when applicable.
You may not qualify if…
- Participants meeting any of the following criteria will be excluded:
- Inability to provide informed consent, or when applicable, the absence of a legally authorized representative able to provide consent for prospective participation.
- Insufficient clinical information available to support study objectives.
- Pregnant women
Where it is running
- UT MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.